Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus

计划入组 60 人 · 首次发布于 2017 年 7 月 27 日

Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration

计划入组 1,502 人 · 首次发布于 2018 年 12 月 5 日

Use of Sitagliptin to Decrease Microalbuminuria

计划入组 142 人 · 首次发布于 2014 年 1 月 29 日

TRC-8XXX

Sitagliptin(Janumet, Januvia, Ristaben, Steglujan, Tesavel, Velmetia, Xelevia, Sitagliptin SUN, Sitagliptin Accord, Ristfor, Efficib, Sitagliptin / Metformin hydrochloride Mylan, Sitagliptin / Metformin hydrochloride Accord)

C₁₆H₁₅F₆N₅O · Rx

Linagliptin(Glyxambi, Jentadueto, Tradjenta, Trajenta, Trijardy)

C₂₅H₂₈N₈O₂ · Rx

Xi'an No.4 Hospital

China

Guiyang No.4 People's Hospital

China

Huai'an No.4 People's Hospital

China

Mass General Brigham Study Links Glipizide to 13% Higher Cardiovascular Risk in Type 2 Diabetes Patients

SGLT-2 Inhibitors Linked to Reduced Dementia and Parkinson's Risk in Type 2 Diabetes Patients

SGLT-2 Inhibitors Linked to Reduced Dementia Risk in Type 2 Diabetes Study